THE EFFECT OF THE PLASMA-LEVELS OF PROTEIN-C AND PROTEIN-S ON THE PREDICTION OF WARFARIN MAINTENANCE DOSE REQUIREMENTS

被引:3
作者
LUBETSKY, A
SELIGSOHN, U
EZRA, D
HALKIN, H
机构
[1] CHAIM SHEBA MED CTR, DEPT MED A, IL-52621 TEL HASHOMER, ISRAEL
[2] TEL AVIV UNIV, ICHILOV HOSP, INST HEMATOL, IL-69978 TEL AVIV, ISRAEL
[3] TEL AVIV UNIV, SACKLER SCH MED, TEL AVIV, ISRAEL
关键词
D O I
10.1038/clpt.1992.101
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: Determination of the effects of the vitamin K-dependent anticoagulants, proteins C and S, on warfarin dose requirements and on the prediction error of a bayesian warfarin dose predicting program. Methods: Patients in the study were consecutive inpatients (n = 18) starting treatment with warfarin who were monitored as outpatients for 4 weeks. The following measurements were taken: repeated (n = 8) prothrombin times, expressed as the international normalized ratio (INR), plasma protein C and S antigen levels (percentage of pooled normal plasma), demographic, clinical and biochemical variables. Results: Maintenance doses (adjusted to INR 2.5) were 6.7 +/- 3.4 mg/day. Protein C decreased to 56.9% +/- 15.3%, protein S to 63.7% +/- 17.3%, INR increased to 2.46 +/- 0.14. Prediction error decreased from 2.84 +/- 2.0 mg/day to 0.95 +/- 0.78 mg/day. Protein C accounted for only 4.2% of the mean maintenance dose but protein C and S levels accounted for 31% of the mean dose prediction error. Conclusion: Protein C and S levels affect warfarin doses and predictions significantly but not to a clinically meaningful degree.
引用
收藏
页码:42 / 49
页数:8
相关论文
共 37 条
[1]   EVALUATION OF A COMPUTER-ASSISTED METHOD FOR INDIVIDUALIZED ANTICOAGULATION - RETROSPECTIVE AND PROSPECTIVE STUDIES WITH A PHARMACODYNAMIC MODEL [J].
ABBRECHT, PH ;
OLEARY, TJ ;
BEHRENDT, DM .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (01) :129-136
[2]   HEREDITARY WARFARIN RESISTANCE - INVESTIGATION OF A RARE PHENOMENON [J].
ALVING, BM ;
STRICKLER, MP ;
KNIGHT, RD ;
BARR, CF ;
BERENBERG, JL ;
PECK, CC .
ARCHIVES OF INTERNAL MEDICINE, 1985, 145 (03) :499-501
[3]  
Bovill E G, 1987, Adv Exp Med Biol, V214, P17
[4]   EVALUATION OF A BAYESIAN REGRESSION PROGRAM FOR PREDICTING WARFARIN RESPONSE [J].
BOYLE, DA ;
LUDDEN, TM ;
CARTER, BL ;
BECKER, AJ ;
TAYLOR, JW .
THERAPEUTIC DRUG MONITORING, 1989, 11 (03) :276-284
[5]  
BROEKMANS AW, 1983, THROMB HAEMOSTASIS, V49, P251
[6]  
CERMEER C, 1991, THROMB HAEMOSTASIS, V66, P153
[7]   THE REGULATION OF HEMOSTASIS - THE PROTEIN-C SYSTEM [J].
CLOUSE, LH ;
COMP, PC .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (20) :1298-1304
[8]   RELATIONSHIP BETWEEN PROTEIN-C ANTIGEN AND ANTICOAGULANT ACTIVITY DURING ORAL ANTICOAGULATION AND IN SELECTED DISEASE STATES [J].
DANGELO, SV ;
COMP, PC ;
ESMON, CT ;
DANGELO, A .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (02) :416-425
[9]  
DRAPER NR, 1981, APPLIED REGRESSION A, P207
[10]   THERAPEUTIC CONTROL OF ANTICOAGULANT TREATMENT [J].
DUXBURY, BM .
BRITISH MEDICAL JOURNAL, 1982, 284 (6317) :702-704